Artivion, Inc. (AORT) — Fair Value Analysis
Base-case fair value (P50): $26.57 · Current price: $29.14 · Verdict: Fairly Valued
The Verdict on AORT
Based on our comprehensive Monte Carlo simulations, ARTIVION INC (AORT) is currently assessed as Fairly Valued. While the current market price of $29.14 trades at a slight premium to our median fair value (P50) of $26.57, resulting in a -8.8% difference, this differential falls within the acceptable range for a "Fairly Valued" rating. Our Monte Carlo analysis, which models thousands of potential future scenarios, suggests that AORT's market price is largely aligned with its intrinsic worth given its current fundamentals and future projections. Investors should note this balance between market valuation and calculated fair value.
How AORT stacks up against Healthcare
AORT's quality tier is rated as "average" when compared to other companies within the Healthcare sector. This "average" rating reflects ARTIVION INC’s operational and financial health, indicating a performance profile that is neither exceptionally strong nor concerningly weak relative to its industry peers. This average quality tier supports the "Fairly Valued" verdict, suggesting that the company’s intrinsic value, which underpins our $26.57 estimate, appropriately reflects its standing within a competitive sector. The market's current valuation at $29.14 appears to largely incorporate this average quality profile.
What this means for investors
For investors considering AORT, the "Fairly Valued" verdict implies that the current $29.14 offers limited immediate arbitrage opportunities based purely on our median fair value of $26.57. The -8.8% reflects this near-equilibrium. An average quality tier suggests a balanced risk-reward profile within the Healthcare sector, where investors are paying a price commensurate with the company's fundamental strength. To understand the full spectrum of possibilities for AORT, including the bear (P10) and bull (P90) case scenarios and the probability of upside, sign up for a free FairCurve account.
Frequently Asked Questions
Is AORT overvalued or undervalued right now?
Based on our Monte Carlo simulations, ARTIVION INC (AORT) is currently assessed as Fairly Valued. While our median fair value (P50) is $26.57, and its current price is $29.14, the price falls within a reasonable range of its intrinsic worth.
What is the bear case and bull case for AORT?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) price targets, along with the probability of upside, is available to users with a free FairCurve account. We do not publish specific dollar values for these scenarios publicly.
How does FairCurve calculate AORT's fair value?
FairCurve calculates AORT's fair value using proprietary Monte Carlo simulations that model thousands of forward scenarios for key financial inputs. This provides a robust range of potential outcomes and a probability-weighted median fair value.
How can I track AORT's fair value as it changes?
You can add AORT to a free FairCurve watchlist to receive daily fair-value updates. FairCurve will instantly re-value AORT when new earnings or significant fundamental data are released.